| HASI price | $37.87 at the July 31, 2026 close, down 0.24% on the day | StockAnalysis.com real-time quote | August 3, 2026 |
| Market capitalization | $4.89 billion, computed as $37.87 x 129.16 million shares outstanding | StockAnalysis.com quote and statistics | August 3, 2026 |
| Q1 2026 adjusted results | Adjusted EPS of $0.77, up 20% year over year from $0.64; adjusted earnings of $102 million, up 31%; record adjusted ROE of 15.7% versus 12.8% | HASI Q1 2026 earnings release and earnings call | May 7, 2026 |
| Q1 2026 operating metrics | Adjusted recurring net investment income up 29% year over year to just over $100 million; managed assets up 13% to $16.4 billion; portfolio yield of 9.2% up 90 basis points year over year; new asset yields above 10.5% for the eighth straight quarter | HASI Q1 2026 earnings call | May 7, 2026 |
| Q1 2026 volume and pipeline | Total volume of $637 million, of which $462 million will be held at CCH1 and on the balance sheet; pipeline greater than $6.5 billion; 2026 investment expectation of $2 billion to $3 billion | HASI Q1 2026 earnings call | May 7, 2026 |
| Q1 2026 gain on sale and fees | Gain on sale of $23 million in Q1 2026, with management expecting lower gain on sale in the remaining quarters; upfront fees from CCH1 and advisory fees contributed $9 million | HASI Q1 2026 earnings call | May 7, 2026 |
| Q1 2026 GAAP results | GAAP net loss of about $72 million attributable to common, driven by an HLBV loss related to the timing of tax credit sale proceeds distributed to tax equity investors, which management expects to fully reverse in Q2 2026 | HASI Q1 2026 Form 10-Q and SEC EDGAR XBRL | August 3, 2026 |
| 2028 guidance | Adjusted EPS of $3.50 to $3.60 and adjusted ROE of 17%, reaffirmed at Q1 2026 | HASI Q1 2026 earnings call | May 7, 2026 |
| Equity funding | No shares issued through the ATM in Q1 2026; minimal additional issuance expected in 2026 based on current funding expectations | HASI Q1 2026 earnings call | May 7, 2026 |
| February 2026 refinancing | Issued $400 million of 6% senior notes and $600 million of 7.8% junior subordinated notes; retired $450 million of 2027 senior bonds at 8%; weighted average maturity of corporate term debt extended from 7.9 to 12.8 years | HASI Q1 2026 earnings call | May 7, 2026 |
| June 2026 green notes | Priced $1.0 billion of 5.950% green senior unsecured notes due 2033 on June 16, 2026 | HASI press release via Business Wire | June 16, 2026 |
| Neogenyx joint venture | Jointly launched Neogenyx with Ameresco, a spin-off of Ameresco biofuels, with an initial HASI investment of $400 million, 30% ownership, and a priority position on debt cash distributions | HASI Q1 2026 earnings call | May 7, 2026 |
| CCH1 co-investment platform | CCH1 assets of $2.3 billion as of Q1 2026; fee-generating assets up 130% year over year to $1.1 billion; CCH1 private debt placement priced at a spread of 195 basis points to the 10-year Treasury | HASI Q1 2026 earnings call | May 7, 2026 |
| FY2025 adjusted EPS | $2.70 for FY2025, up from $2.45 in FY2024, about a 10% increase | StockAnalysis.com forecast financial forecast | August 3, 2026 |
| 2026 and 2027 consensus estimates | FY2026 adjusted EPS of $2.99, up 10.7%; FY2027 adjusted EPS of $3.30, up 10.5%; FY2026 revenue estimate of $120.92 million and FY2027 revenue estimate of $215.67 million | StockAnalysis.com forecast financial forecast | August 3, 2026 |
| Dividend | Quarterly dividend of $0.425 per share, annual dividend of $1.70, forward yield of 4.49%, ex-dividend date July 2, 2026, with dividend growth of 1.20% year over year and 7 consecutive years of growth | StockAnalysis.com dividend history | August 3, 2026 |
| Analyst consensus | Buy rating across 16 analysts with an average price target of $49.27, about 30% above the July 31, 2026 close, a median of $50, and a range of $41 to $57 | StockAnalysis.com forecast and analyst ratings | August 3, 2026 |
| Analyst rating mix, July 2026 | 10 Strong Buy, 4 Buy, 2 Hold, 0 Sell out of 16 analysts | StockAnalysis.com forecast recommendation trends | August 3, 2026 |
| Recent analyst target updates | Citi maintains Buy at $50 on July 23; J.P. Morgan maintains Buy at $50 on July 21; RBC maintains Buy at $48 on July 18; Goldman Sachs maintains Hold at $43 on June 17; Morgan Stanley raised to $57 from $54 on May 27 | StockAnalysis.com forecast analyst actions | July 23, 2026 |
| Balance sheet as of March 31, 2026 | Cash and cash equivalents of $124.5 million, total assets of $8.202 billion, long-term debt of $5.002 billion, and stockholders equity of $2.535 billion, matching the Q1 2026 Form 10-Q and SEC EDGAR XBRL | HASI Q1 2026 Form 10-Q and SEC EDGAR XBRL | August 3, 2026 |
| Current balance sheet per S&P Global | Cash of $150.5 million, total debt of $5.39 billion, net cash of negative $5.24 billion, book value of $2.53 billion, and book value per share of $19.21, per the StockAnalysis.com statistics page | StockAnalysis.com statistics | August 3, 2026 |
| Valuation check | Trailing PE of 87.76, forward PE of 12.58, PS of 55.64, PB of 1.97, P/TBV of 2.00, P/OCF of 22.23, and PEG of 1.08 | StockAnalysis.com statistics | August 3, 2026 |
| Short interest | 10.93 million shares short, 8.46% of shares outstanding, 8.71% of float, and 11.03 days to cover, down from 11.19 million the prior month | StockAnalysis.com statistics short selling | August 3, 2026 |
| Trailing free cash flow | Operating cash flow of $220.05 million over TTM, with free cash flow of $220.05 million because capital expenditures are not material | StockAnalysis.com cash flow statement | August 3, 2026 |
| 52-week range and beta | 52-week range of $24.38 to $44.13, 52-week price change of plus 41.04%, and a beta of 1.42 | StockAnalysis.com statistics | August 3, 2026 |
| Next earnings date | Q2 2026 earnings scheduled for August 6, 2026 after market close, announced July 20, 2026 | HASI press release via Business Wire and StockAnalysis.com | July 20, 2026 |
| Technical snapshot | 5-day SMA near $38.13, 20-day SMA near $38.10, 50-day SMA near $38.80, 100-day SMA near $38.96, 200-day SMA near $36.14, 14-day RSI near 45.24, 14-day ADX near 21.65, 14-day historical volatility near 20.36%, 20-day average volume near 0.80 million shares | Barchart and StockAnalysis.com technical snapshots | August 3, 2026 |